HIPO Form 144: Planned Sale of 1,819 Common Shares on NYSE

HIPO filed a Form 144 covering a planned sale of 1,819 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $57,371.26.

Rhea-AI Filing Summary

HIPO filed a Form 144 covering a planned sale of 1,819 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $57,371.26. These shares come from restricted stock units acquired from the issuer on 11/15/2025, with payment also dated 11/15/2025. The filing notes that 25,335,179 shares of common stock were outstanding, providing a baseline for the company’s total equity. Over the prior three months, a Rule 10b5-1 trading plan for Guy Zeltser reported sales of 5,177 common shares for gross proceeds of $194,031.73.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HIPO Form 144 filing disclose?

The Form 144 for HIPO discloses a proposed sale of 1,819 shares of common stock on the NYSE through Morgan Stanley Smith Barney LLC, with an aggregate market value of $57,371.26, based on current market prices.

How many HIPO shares are planned to be sold under this Form 144?

The notice covers the planned sale of 1,819 shares of HIPO common stock, to be sold on the NYSE through Morgan Stanley Smith Barney LLC.

What is the source of the HIPO shares being sold?

The 1,819 HIPO common shares to be sold were acquired as restricted stock units from the issuer on 11/15/2025, with the amount of securities acquired and the date of payment both listed as 1,819 and 11/15/2025.

How many HIPO shares were outstanding at the time of this notice?

The filing states that 25,335,179 shares of HIPO common stock were outstanding, giving context for the size of the planned 1,819-share sale.

Were there recent HIPO share sales by the same person before this Form 144?

Yes. The filing lists 10b5-1 sales for Guy Zeltser on 09/17/2025 of 5,177 common shares, with gross proceeds of $194,031.73 during the past three months.

On which exchange will the HIPO shares be sold and through which broker?

The 1,819 HIPO common shares are indicated to be sold on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York, NY.

What assurance does the seller give about non-public adverse information on HIPO?

The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/18/2025 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002061058
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HIPPO HOLDINGS INC.
SEC File Number	001-39711
Address of Issuer	One Almaden Blvd., Suite 400 San Jose CALIFORNIA 95113
Phone	6502948463
Name of Person for Whose Account the Securities are To Be Sold	GUY ZELTSER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1819	57371.26	25335179	11/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/15/2025	Restricted Stock Units	Issuer			1819	11/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for GUY ZELTSER One Almaden Blvd., Suite 400 San Jose CA 95113	Common	09/17/2025	5177	194031.73

144: Remarks and Signature

Remarks
Date of Notice	11/18/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Guy Zeltser
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)